These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Epidemiological investigation of beta-lactam antibiotic induced vancomycin-resistant MRSA from clinical isolated MRSA--comparison of detection rate of BIVR with or without CZX]. Hososaka Y; Hanaki H; Hayashi I; Kamibeppu K; Sunakawa K Kansenshogaku Zasshi; 2004 Aug; 78(8):717-21. PubMed ID: 15478647 [TBL] [Abstract][Full Text] [Related]
6. Rapid depletion of free vancomycin in medium in the presence of beta-lactam antibiotics and growth restoration in Staphylococcus aureus strains with beta-lactam-induced vancomycin resistance. Yanagisawa C; Hanaki H; Matsui H; Ikeda S; Nakae T; Sunakawa K Antimicrob Agents Chemother; 2009 Jan; 53(1):63-8. PubMed ID: 18936187 [TBL] [Abstract][Full Text] [Related]
7. [Epidemiology and clinical effect against "beta-lactam antibiotic induced vancoymcin-resistant MRSA (BIVR)"]. Hanaki H Jpn J Antibiot; 2004 Apr; 57(2):204-12. PubMed ID: 15219058 [No Abstract] [Full Text] [Related]
8. Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration. Yamaguchi Y; Hanaki H; Yanagisawa C; Ikeda-Dantsuji Y; Hashimoto T; Yazaki H; Sugahara K; Yanagisawa T; Kawajiri H; Sato S; Ishizaki A; Tachihara-Sato R; Takahashi Y; Ono T; Kageyama Y; Kawaguchi T; Tamura A; Hagane K; Sunakawa K J Infect Chemother; 2009 Oct; 15(5):274-8. PubMed ID: 19856063 [TBL] [Abstract][Full Text] [Related]
9. [Combined effect of vancomycin or teicoplanin plus a beta-lactam antibiotic in mouse infection models caused by beta-lactam antibiotec-induced vancomycin resistant MRSA (BIVR)]. Hatano K; Yokota Y; Hanaki H; Sunakawa K Kansenshogaku Zasshi; 2006 May; 80(3):243-50. PubMed ID: 16780131 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic susceptibility survey of blood-borne MRSA isolates in Japan from 2008 through 2011. Hanaki H; Cui L; Ikeda-Dantsuji Y; Nakae T; Honda J; Yanagihara K; Takesue Y; Matsumoto T; Sunakawa K; Kaku M; Tomono K; Fukuchi K; Kusachi S; Mikamo H; Takata T; Otsuka Y; Nagura O; Fujitani S; Aoki Y; Yamaguchi Y; Tateda K; Kadota J; Kohno S; Niki Y J Infect Chemother; 2014 Sep; 20(9):527-34. PubMed ID: 25066429 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of rapid antimicrobial susceptibility test for Staphylococcus aureus by chemiluminescent assay and its application for screening of beta-lactam antibiotic induced vancomycin-resistant MRSA]. Nagasawa Z; Nakashima Y; Oho M; Kusaba K; Manome I; Nagayama A Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2008; 19(1-2):7-15. PubMed ID: 19583457 [TBL] [Abstract][Full Text] [Related]
12. Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection. Takata T; Miyazaki M; Futo M; Hara S; Shiotsuka S; Kamimura H; Yoshimura H; Matsunaga A; Nishida T; Ishikura H; Ishikawa T; Tamura K; Tsuji BT Scand J Infect Dis; 2013 Mar; 45(3):203-12. PubMed ID: 23113753 [TBL] [Abstract][Full Text] [Related]
17. The antagonistic effects of a combination of vancomycin and minocycline in Staphylococcus aureus with heterogeneous resistance to vancomycin. Oshiro T; Nagasawa Z; Hanaki H; Ikeda-Dantsuji Y; Nagayama A J Infect Chemother; 2008 Feb; 14(1):15-22. PubMed ID: 18297444 [TBL] [Abstract][Full Text] [Related]
18. Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin. Aritaka N; Hanaki H; Cui L; Hiramatsu K Antimicrob Agents Chemother; 2001 Apr; 45(4):1292-4. PubMed ID: 11257050 [TBL] [Abstract][Full Text] [Related]
19. Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus. Roch M; Clair P; Renzoni A; Reverdy ME; Dauwalder O; Bes M; Martra A; Freydière AM; Laurent F; Reix P; Dumitrescu O; Vandenesch F Antimicrob Agents Chemother; 2014 Sep; 58(9):5306-14. PubMed ID: 24957836 [TBL] [Abstract][Full Text] [Related]
20. Combination Antibiotic Exposure Selectively Alters the Development of Vancomycin Intermediate Resistance in Staphylococcus aureus. Zheng X; Berti AD; McCrone S; Roch M; Rosato AE; Rose WE; Chen B Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]